AUAlina M. Ushanova

Alina M. Ushanova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alina M. Ushanova has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    DAMAGE TO TARGET ORGANS IN PATIENTS WITH ARTERIAL HYPERTENSION AND PERIODONTITIS

    by Alina M. Ushanova, Olga Iu. Trushina, Yuriy L. Vasil’Ev, Dmitry V. Petrovskiy, Natalia V. Morozova, Vera A. Osadchaya, Viktor V. Fomin, Алина Михайловна Ушанова, Ольга Юрьевна Трушина, Юрий Леонидович Васильев, et al.

    Highlights Arterial hypertension is a key modifiable risk factor for cardiovascular diseases and premature mortality, in the pathogenesis of which inflammatory processes play a significant role. Periodontitis, as a chronic inflammatory disease, may be associated with elevated blood pressure and, in patients with hypertension, may increase the risk and severity of target organ damage. Therefore, it is important to study the impact of chronic inflammation associated with periodontitis on the course of hypertension, the degree of target organ damage, and the development of associated clinical conditions. Aim. To determine the prevalence of associated clinical conditions and target organ damage in patients with arterial hypertension and periodontitis. Methods. The study included 150 patients with AH, divided into two groups: with periodontitis (study group, 76 patients) and without periodontitis (control group, 74 patients). Clinical and laboratory parameters were assessed (age, BMI, smoking status, CRP, lipid profile, etc.), as well as target organ damage (left ventricular hypertrophy (LVH) by ECG and echocardiography, retinopathy) and arterial status (pulse wave velocity (PWV) and vascular age (VA)). The diagnosis of periodontitis was established in the presence of clinical attachment loss at two or more non-adjacent interproximal sites with a periodontal probing depth greater than 3 mm. Results. In patients with concomitant AH and periodontitis, hypertension developed at an earlier age (47 years) compared with the group without periodontitis (50 years). Patients with periodontitis had higher levels of systemic inflammation (elevated hs-CRP: 5 mg/L vs 2 mg/L in the control group) and dyslipidemia (higher triglyceride levels). Patients with periodontitis demonstrated statistically significantly higher PWV and VA values, as well as a higher prevalence of LVH and predominance of concentric left ventricular hypertrophy. The prevalence of ACCs (type 2 diabetes mellitus (T2DM), coronary artery disease (CAD), myocardial infarction (MI), and acute cerebrovascular events (stroke)) was significantly higher in the periodontitis group. Conclusions. Periodontitis in patients with arterial hypertension is associated with increased systemic inflammation, more pronounced target organ damage, and a higher risk of associated clinical conditions. Incorporating measures for the prevention and treatment of periodontitis may improve hypertension control and reduce its complications.

  • The impact of periodontitis on the likelihood of developing arterial hypertension and blood pressure control

    by Alina M. Ushanova, Olga Iu. Trushina, Yuriy L. Vasil’EV, Viktor V. Fomin

    Objective . To study the influence of periodontitis on the likelihood of developing and controlling blood pressure levels in patients with arterial hypertension (AH) who are undergoing antihypertensive therapy. Materials and Methods . The study included 150 patients with a confirmed diagnosis of arterial hypertension (AH). Patients were divided into two groups based on the presence or absence of periodontitis. The main group (n=76, 50.6%) had periodontitis and was predominantly female — 47 (61.84%). The average age of this group was 61.11±10.86 years, with a body mass index (BMI) of 29.35±4.28 kg/m². The control group consisted of 74 (49.4%) patients without periodontitis: 42 (56.76%) women, with an average age of 51.7±10.48 years, and BMI of 27.84±4.18 kg/m². The study analyzed the age at which AH was diagnosed, the number of antihypertensive medications used for BP control, and their effectiveness, assessed through 24-hour ambulatory blood pressure monitoring (ABPM). Results . In patients with periodontitis, arterial hypertension develops at a younger age — 47.5 [42; 54] years — compared to patients without periodontitis — 51.5 [48; 55] years (p=0.002). A trend toward prescribing a greater number of antihypertensive medications was observed in the group of patients with periodontitis. According to the data, 35 (46.05%) patients with periodontitis take three or more medications, whereas among patients without periodontitis, there are 29 (39.1%) cases; however, no statistically significant difference was found (p=0.051). Analysis of the ABPM data revealed significant differences in the average daytime and nighttime systolic and diastolic blood pressure values, as well as in the hypertensive index of time for diastolic blood pressure. Conclusions . Periodontitis significantly complicates blood pressure control by contributing to the earlier onset of hypertension and increasing the number of medications required.


  • Open Access

    Prevention of thrombotic complications in patients in the postoperative period of total hip and knee arthroplasty: efficacy and safety

    by A. M. Ushanova, E. A. Okisheva, O. Iu. Mironova

    Thromboembolic complications (TEC) remain a significant problem in modern surgery, worsening the prognosis and reducing the effectiveness of the operation performed. The increase in the number of venous thromboembolisms (VTE) is determined by the severity of the initial injuries, the volume and traumatic nature of the surgical intervention, as well as the increase in the number of elderly patients with multiple comorbidities. Patients in orthopedic departments who have undergone major surgeries such as total hip arthroplasty (THA) or total knee arthroplasty (TKA) are at increased risk of VTE, leading to significant postoperative morbidity and mortality. Thromboses in extensive orthopedic surgery are caused by several prothrombotic mechanisms, such as venous injury, activation of procoagulation factors due to massive bone and tissue damage, and prolonged postoperative immobilization. The most common potential thrombotic complications after arthroplasty are deep vein thrombosis (DVT) of the lower extremities and pulmonary embolism (PE).In the absence of prophylaxis in the postoperative period of major orthopedic surgeries, TECs develop in most patients.To date, the issue of primary prevention of VTE in orthopedic patients remains relevant, and there is still no consensus on the best way to prevent thrombosis after THA and TKA.Risk assessment is the first step in preventing death and disability from VTE. Currently, mechanical and pharmacological methods are used for primary prevention in orthopedics, often in combination. Certainly, the use of antithrombotic drugs in the postoperative period is an effective way to prevent thrombosis. When prescribing antithrombotic drugs, it is also important to minimize the risk of bleeding, including in the area of postoperative wounds. Various antithrombotic drugs are used as pharmacological prophylaxis for TEC. The literature on the dosage, duration, efficacy, and safety of their use varies considerably. Our review assessed published literature on the efficacy and safety of antiplatelet agents for VTE prophylaxis.


  • The impact of left atrial appendage occlusion on the rhythm control in atrial fibrillation: a prospective cohort study

    by D.V. Pevzner, I.A. Merkulova, A.L. Komarov, G.K. Arutyunyan, A.M. Ushanova, O.O. Shakhmatova, E.V. Merkulov, I.E. Chazova


  • Open Access

    Experience with various occluder types for endovascular hemodynamic isolation of the left atrium appendage in patients with non-valvular atrial fibrillation

    by D. V. Pevzner, E. V. Merkulov, G. K. Arutyunyan, A. L. Komarov, O. O. Shakhmatova, A. M. Ushanova, I. A. Merkulova, K. V. Davtyan, I. E. Chazova

    The aimof our study was to evaluate implantation efficacy and safety across various occluder types and to identify factors determining device selection.Methods. This single-site prospective observational study included patients above the age of 40 years with non-valvular atrial fibrillation (AF) and high thromboembolic risk, undergoing endovascular isolation of the left atrium appendage (LAA) with Watchman or Amplatzer Cardiac Plug/Amulet devices. Occluders were implanted to patients without either had contraindications to anticoagulant therapy (ACT) or refused ACT. We evaluated technical aspects of device implantation, short- and long-term outcomes of the intervention over 3 years of follow-up.Results. 90 patients were enrolled in the study (62 into the Watchman arm and 28 into the Amplatzer arm). Interventions were technically successful in 89 cases. In 1 patient (1/90, 1.1%) technical success was not achieved due to device migration (Amplatzer Amulet). The incidence of early (occurring within˂ 24 hours) implantation complications was 0% in the Watchman arm, and 3.6% in the Amplatzer arm (1/28) (р=0.135) (device migration). The cumulative incidence of all in-hospital complications was 11.3% and 14.3%, respectively (р=0.734). No significant differences between arms were found in the incidence of device thrombosis within 90 days post-implantation (3.3% in the Watchman’s arm and 8.3% in the Amplatzer arm, р=0.316). During the observation period, there were no significant differences in comparison groups in the incidence of net clinical efficacy endpoint events (р=0.58). The bleeding rate was 17.7% and 14.3%, respectively, р=0.769. No factors influencing the choice of the device could be identified reliably; however, there was a trend towards Watchman preference for appendage anatomic variants such as broccoli and cactus. Amplatzer was preferred in patients with contraindications to ACT.Conclusion.Implantation of Watchman and Amplatzer Amulet occluders is equally effective and safe in preventing thromboembolism in patients with AF not receiving ACT for various reasons. The individual choice of a device may be influenced by appendage anatomy and indications to occluder implantation.


  • Open Access

    Non-ST-segment elevation acute coronary syndrome in elderly patients and long-livers. Features of treatment. Literature review and case report

    by R. G. Gulyan, A. M. Ushanova, Y. K. Rytova, D. V. Pevsner, E. V. Merkulov, S. A. Boytsov

    Despite the growing population of elderly people and long-livers every year, the treatment of acute coronary syndrome in these groups is not fully developed and is not regulated in clinical guidelines due to the lack of large randomized clinical trials. The article presents a literature review covering the following issues arising during clinical decision-making in the treatment of non-ST-segment elevation acute coronary syndrome in this group of patients: selection of invasive treatment strategy, scope of myocardial revascularization, appointment of dual antiplatelet therapy taking into account the bleeding risk, decreased renal function and senile asthenia. In addition, a case report of successful treatment of a 101-year-old female patient with non-ST-segment elevation myocardial infarction, who underwent percutaneous coronary intervention with stenting of infarct-related artery, was presented.